A total of 109 cases of the JN.1 sub-variant have been detected in...
Category:
Health
Latest
Indian general insurers see record underwriting losses of Rs31,810 crore in Fy 2022-23, PSU general insurers shut 1,148 offices
The public sector insurers' underwriting losses, with OIC's largest...
Arsenic and fluoride in groundwater: NGT issues notices to 24 states, 4 UTs
The report stated that arsenic was detected in groundwater in parts...
Emerging Asia: a $3.8 trillion-per-year pension savings gap
“The shortfall in saving for adequate and sustainable retirements cannot be bridged solely by government resources. Strong partnership between the state, the private sector and individuals will be key.Protecting people throughout their saving lifecycle has the potential to reduce poverty, ill-health and even social unrest, and should form a core building block of emerging markets’ longterm economic growth,” ,” said Jerome Jean Haegeli,Group Chief Economist, Swiss Re
COVID-19 in children often asymptomatic, 2pc-3 pc infected kids may require hospitalisation: VK Paul
Dr Randeep Guleria, Director of All India Institute of Medical Sciences (AIIMS) New Delhi has said that there is no data, either from India or globally, to show that children will be seriously infected in subsequent waves.
India asks EU member states to consider Covishield, Covaxin vaccines under Green Pass scheme
India has requested the EU member nations to accept the vaccination certificate issued through the CoWIN portal.
The European Union”s Digital COVID certificate or “Green Pass” will be rolled out on Thursday with an aim to facilitate free movement during the COVID-19 pandemic is to come into effect on Thursday.
Highly transmissible Covid Delta variant detected in 96 countries, says WHO
Furthermore, a recent study conducted in Scotland and published in the international medical journal Lancet found that the hospitalization rate for patients infected with the Delta variant of COVID-19 was 85 per cent higher than for those infected with the Alpha variant.
“This particular Delta variant is faster, it is fitter, it will pick off the more vulnerable more efficiently than previous variants,” Michael Ryan, executive director of the WHO’s Health Emergencies Program, has commented recently.
17 pc dip in average fresh COVID-19 cases since 2nd Corona wave peak in May, says Union Health Ministry
The Union Health Ministry further added that a total of 51 Delta plus variant cases reported in India. In regard to the Moderna COVID-19 vaccine, Dr VK Paul, Member-Health of Niti Aayog said, “New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use.”
Cipla gets DCGI nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India: Sources
According to the sources, approval is likely anytime as the Central Drugs Standard Control Organisation (CDSCO) is in favor of granting permission to Cipla for import of Moderna’s COVID-19 vaccine for restricted emergency use in India considering the pandemic situation in the country and the public interest.
Johnson & Johnson exploring ways to accelerate delivery of its COVID vaccine in India
‘We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver the Johnson & Johnson single dose COVID-19 vaccine to the people of India,” Johnson & Johnson India spokesperson said in a statement.
As per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India, the statement added.
Five Indian drugmakers to jointly start local trial of Merck & Co’s COVID-19 drug
Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.
Oxford study says mixing COVID-19 vaccines gives good protection
Professor Snape said these results are an invaluable guide to the use of mixed dose schedules, but the interval of four weeks studied here is shorter than the eight to 12-week schedule most commonly used for the Oxford-AstraZeneca vaccine.
Doubling time of coronavirus cases in India improves to 17.4 days: Health ministry
During the meeting with the cabinet secretary, the states were advised to focus on containment, testing and tracing, upgrading health infrastructure, clinical management and community engagement for effective management of COVID-19.